2026-10-23 15:00:09 UTC#507535duplicateconfirmednews
Quest Diagnostics (DGX) stock news
Quest Diagnostics (DGX) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-22 22:20:00 UTC#503257newconfirmednews
Quest Diagnostics average analyst price target raised to $254.50, implies 7% upside
tradingviewimportance 0.30trust 0.70Quest Diagnostics Incorporated +0.30FactSet Research Systems Inc. 0
2026-10-22 17:28:21 UTC#501656updateconfirmednews
Quest Diagnostics projects 2026 revenue of $12.065B-$12.105B, expects consumer health growth over 30%
2026-10-22 15:46:49 UTC#501129duplicateconfirmednews
Quest Diagnostics reiterates 2026 revenue and EPS guidance following Q3 earnings beat
2026-10-22 14:35:59 UTC#500814duplicateconfirmednews
Quest Diagnostics Q3 results and FY26 guidance raise confirmed; PAMA cuts cited as 2027 headwind
2026-10-22 11:54:54 UTC#499777duplicateconfirmednews
Quest Diagnostics confirms unauthorized access to Quanum LSM system on October 21, 2026
2026-10-22 11:41:01 UTC#499676newreportednews
Quest Diagnostics reports cyber breach affecting patient records, Reuters reports
2026-10-22 11:16:23 UTC#499532newconfirmednews
Quest Diagnostics (DGX) Q3 revenue up 10%, adjusted EPS up 15.4%; raises FY26 guidance
2026-10-22 10:55:18 UTC#499358duplicateconfirmednews
Quest Diagnostics Q3 revenue and EPS beat expectations, full-year 2026 guidance raised
2026-10-22 10:48:45 UTC#499245duplicateconfirmednews
Quest Diagnostics Q3 Non-GAAP EPS $3.00 beats by $0.13, Revenue $3.1B beats by $50M
2026-10-22 10:48:00 UTC#499264updateconfirmednews
Quest Diagnostics reaffirms 2026 capital expenditure guidance of approximately $550 million
2026-10-22 10:48:00 UTC#499263updateconfirmednews
Quest Diagnostics raises 2026 cash provided by operations guidance to $1.9B from $1.8B
2026-10-22 10:46:00 UTC#499232newconfirmedpress release
Quest Diagnostics Q3 2026 Revenue $3.10B (+10% YoY), Adj. EPS $3.00 (+15.4% YoY); Raises Full-Year 2026 Guidance
2026-10-21 17:11:26 UTC#494634newforecastanalysis
Quest Diagnostics Q3 2026 Earnings Preview
2026-10-07 15:27:00 UTC#426730newconfirmednews
Barclays raises Quest Diagnostics (DGX) price target to $260 from $250
2026-10-06 20:33:02 UTC#421994newconfirmednews
Quest Diagnostics EVP Catherine T. Doherty to transition role Nov 1, 2026, ahead of July 2027 retirement
tradingviewimportance 0.30trust 0.80Quest Diagnostics Incorporated 0Catherine T. Doherty 0Corewell Health 0
2026-09-29 20:17:48 UTC#387189newconfirmednews
Renalytix partners with Quest Diagnostics to scale KidneyIntelX, targeting 25,000 tests in 2027
quartrimportance 0.60trust 0.70Renalytix plc +0.70Quest Diagnostics Incorporated +0.60KidneyIntelX +0.70
2026-09-22 20:28:00 UTC#351738newconfirmedpress release
Quest Diagnostics to report Q3 2026 financial results on October 22, 2026
2026-09-22 13:25:00 UTC#349101duplicateconfirmednews
Labcorp and Quest Diagnostics shares remain lower following CMS proposal to cut Medicare lab payments
dow_jonesimportance 0.40trust 0.90Centers for Medicare & Medicaid Services -0.50Labcorp Holdings Inc. -0.60Quest Diagnostics Incorporated -0.60+1 entities
2026-09-22 13:17:17 UTC#349015newconfirmednews
Premarket movers: Alibaba unveils AI chip, GameStop and Grab CEOs disclose large stock purchases, Quest Diagnostics falls
zerohedgeimportance 0.40trust 0.40Alibaba Group Holding Limited +0.50Nvidia Corporation -0.20GameStop Corp. +0.50+2 entities